Rudolf de Boer

Rudolf de Boer is a Full Professor of Cardiology at Erasmus MC in Rotterdam, Netherlands, with clinical and research expertise in heart failure, cardiogenetics, cardio-oncology, obesity, diabetes, HFpEF, and biomarkers. He has held leadership roles including President-Elect of the Dutch Cardiac Society and former board member of the Heart Failure Association (HFA) of the European Society of Cardiology (2014–2020).

• PhD, Neurohormonal activation, angiogenesis, and heart failure (Erasmus MC, 2002)
• Postdoctoral Fellowship, Brigham and Women's Hospital, Harvard Medical School (2002–2003)
• Medical Doctor (MD) from Rijksuniversiteit Groningen (1991–1998)

His research focuses on heart failure mechanisms, including biomarker discovery (Galectin-3, Dapagliflozin) and cardiometabolic interactions (obesity, diabetes). Recent studies explore proteomic links to diastolic dysfunction, nicotinamide-methyltransferase inhibition in HFpEF, and systemic short-chain fatty acid alterations in heart failure patients.

• Scientific Awards: Joe Loscalzo Award (2019), ERA-CVD Prize for Best Basic Paper (2018)
• Leadership: Associate Editor, European Heart Journal (Heart Failure section); former Associate Editor, European Journal of Heart Failure